Quick Answer
TherapeuticsMD, Inc. reported Stockholders Equity of $26.88 million for the year ending 2025.
- TherapeuticsMD, Inc. showed a decrease of -1.8% in Stockholders Equity from 2024 to 2025.
- This data is from TherapeuticsMD, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $38.47 million | Q3 2013: $62.09 million | Q1 2014: $46.75 million | Q2 2014: $37.48 million | Q3 2014: $63.60 million | Q1 2015: $87.72 million | Q2 2015: $63.01 million | Q3 2015: $77.56 million | Q1 2016: $183.37 million | Q2 2016: $167.25 million | Q3 2016: $146.35 million | Q1 2017: $110.33 million | Q2 2017: $93.59 million | Q3 2017: $149.48 million | Q1 2018: $107.30 million | Q2 2018: $77.55 million | Q3 2018: $134.22 million | Q1 2019: $60.69 million | Q2 2019: $8.09 million | Q3 2019: -$21.23 million | Q1 2020: -$45.21 million | Q2 2020: -$94.09 million | Q3 2020: -$116.03 million | Q1 2021: -$9.48 million | Q2 2021: -$49.07 million | Q3 2021: -$57.36 million | Q1 2022: -$140.58 million | Q2 2022: -$26.07 million | Q3 2022: -$48.27 million | Q1 2023: $32.02 million | Q2 2023: $31.20 million | Q3 2023: $28.05 million | Q1 2024: $28.66 million | Q2 2024: $27.67 million | Q3 2024: $27.09 million | Q1 2025: $26.74 million | Q2 2025: $27.29 million | Q3 2025: $27.44 million.
- Over the full 15 years of available data (2011 to 2025), TherapeuticsMD, Inc.'s Stockholders Equity has grown by 1,670.0%.
- Historical annual values: Fiscal year 2025: $26.88 million | Fiscal year 2024: $27.37 million | Fiscal year 2023: $29.29 million | Fiscal year 2022: $35.14 million | Fiscal year 2021: -$93.62 million | Fiscal year 2020: -$124.00 million | Fiscal year 2019: $9.20 million | Fiscal year 2018: $97.52 million | Fiscal year 2017: $129.91 million | Fiscal year 2016: $127.49 million | Fiscal year 2015: $63.06 million | Fiscal year 2014: $48.39 million | Fiscal year 2013: $54.70 million | Fiscal year 2012: -$1.43 million | Fiscal year 2011: -$1.71 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: